Qiagen In Crisis, Previews Poor Q3 Sales; Long-Term CEO Steps Down

Qiagen shares took a hit following a series of negative announcements, including lower than expected results for Q3 2019 and the departure of long-term CEO Peer Schatz. The company said it had been affected by poor sales growth in China.

MT1910_Falling blocks_783432529_1200.jpg
• Source: shutterstock.com

More from In Vitro Diagnostics

More from Diagnostics